EUVIMEDEUVIMED entdecken
Crossref

Integrated anticoagulant and antiplatelet activities of a phytochemically standardized scutellarin-rich fraction in rats

Journal of Advanced Biotechnology and Experimental Therapeutics · 2026

DOI: 10.5455/jabet.2026.32 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Advanced Biotechnology and Experimental Therapeutics, 2026. Die Arbeit nennt 87 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plant-derived flavonoids may modulate both coagulation proteases and platelet activation, but integrated evidence across the platelet-coagulation interface remains limited. This study evaluated a phytochemically standardized scutellarin-rich fraction (SRF) using complementary plasma, platelet, whole-blood, pharmacodynamic, and ex vivo thrombosis-associated assays. SRF was isolated from the aerial parts of Inula salicina L. and characterized as a scutellarin-dominant flavonoid fraction. Citrated plasma was analyzed for thrombin time (TT), plasma recalcification time (PRT), prothrombin time (PT), and activated partial thromboplastin time (APTT). Platelet-rich plasma was examined by adenosine diphosphate (ADP)-induced aggregometry and Fura-2/AM calcium imaging. Rat thromboelastography, serial clotting-time monitoring, and FeCl3 carotid injury-associated ex vivo plasma assays were used to assess systemic and injury-associated responses. SRF prolonged PRT concentration-dependently in vitro (10-100 µM) and increased TT, PT, and APTT, indicating a broad plasma hypocoagulant phenotype. It also inhibited ADP-induced platelet aggregation, nearly abolished the second aggregation phase, and attenuated agonist-evoked intracellular Ca2+ signaling without behaving as a simple extracellular calcium chelator. In rats, SRF delayed thromboelastographic clot initiation and slowed clot development. Serial pharmacodynamic assays showed rapid route-dependent clotting-time prolongation. In the FeCl3 series, oral SRF dose-dependently shifted the injury-associated hypercoagulable profile toward anticoagulation. These findings suggest that SRF exhibits integrated anticoagulant and antiplatelet activity at the platelet-coagulation interface, consistent with modulation of thrombin-fibrin conversion, membrane-dependent coagulation complex assembly, and calcium-dependent platelet amplification.

Zitieren

APA

(2026). Integrated anticoagulant and antiplatelet activities of a phytochemically standardized scutellarin-rich fraction in rats. Journal of Advanced Biotechnology and Experimental Therapeutics. https://doi.org/10.5455/jabet.2026.32

Vancouver

Integrated anticoagulant and antiplatelet activities of a phytochemically standardized scutellarin-rich fraction in rats. Journal of Advanced Biotechnology and Experimental Therapeutics. 2026. doi:10.5455/jabet.2026.32

BibTeX
@article{euvimed2026,
  title = {Integrated anticoagulant and antiplatelet activities of a phytochemically standardized scutellarin-rich fraction in rats},
  journal = {Journal of Advanced Biotechnology and Experimental Therapeutics},
  year = {2026},
  doi = {10.5455/jabet.2026.32}
}
Kostenlos starten →